Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial
Related Experiment Video
Updated: Aug 17, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Dennis S C Lam1, Dorothy S P Fan, Joan S K Ng
1Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, Chinese University of Hong Kong, Kowloon, Hong Kong. dennislam_pub@cuhk.edu.hk
Insights
Twice-daily topical dexamethasone eye drops effectively control inflammation after strabismus surgery in children. This lower dosage schedule induces less intraocular pressure increase compared to four-times-daily use, suggesting a potentially safer treatment option.
Area of Science:
- Ophthalmology
- Pediatric Surgery
- Pharmacology
Background:
- Topical corticosteroids like dexamethasone are used to manage inflammation post-strabismus surgery.
- The optimal dosage schedule for 0.1% topical dexamethasone in pediatric patients remains under investigation.
- Ocular hypertensive effects of dexamethasone can be a concern, particularly in children.
Purpose of the Study:
- To compare the ocular hypertensive and anti-inflammatory effects of two different dosage schedules (four times daily vs. twice daily) of 0.1% topical dexamethasone.
- To evaluate the safety and efficacy of these dexamethasone regimens in Chinese children undergoing strabismus surgery.
Main Methods:
- 137 children undergoing bilateral strabismus surgery were randomized into two groups.
- Group A received 0.1% dexamethasone eye drops four times daily; Group B received them twice daily for 4 weeks.
- Intraocular pressure (IOP) and ocular inflammation were monitored over an 8-week period.
Main Results:
- Both dosage schedules led to a significant increase in IOP after 4 weeks compared to preoperative levels.
- The four-times-daily group (Group A) showed a significantly greater net increase in IOP than the twice-daily group (Group B).
- Younger children in Group A experienced higher peak IOP and reached it earlier; no significant difference in anti-inflammatory response was observed between groups.
Conclusions:
- The ocular hypertensive effect of topical dexamethasone in children is dependent on dosage and age.
- A twice-daily regimen of 0.1% topical dexamethasone provides effective anti-inflammatory control post-strabismus surgery.
- The twice-daily schedule is associated with a lower increase in IOP, making it a potentially preferable treatment option.
Background:
The purpose of the present study was to investigate the ocular hypertensive and anti-inflammatory responses to two different dosage schedules of 0.1% topical dexamethasone in a population of Chinese children undergoing strabismus surgery.
Methods:
Children undergoing bilateral strabismus surgeries were randomly assigned to receive topical 0.1% dexamethasone eye drops four times daily (group A) or twice daily (group B) for 4 weeks. Intraocular pressure (IOP) and anti-inflammatory responses were monitored for 8 weeks.
Results:
A total of 137 children with mean age 6.5 years (SD, 1.9 years; range, 3-10 years) participated in the study. The IOP increased significantly after 4 weeks in both groups compared to the preoperative values (P < 0.001). Peak IOP ranged from 14.0 to 50.3 mmHg in group A and 11.0-41.3 mmHg in group B. Cases in group A (mean, 13.8 mmHg; SD, 8.4 mmHg) had a greater net increase in IOP than cases in group B (mean, 10.2 mmHg; SD, 6.2 mmHg; P = 0.004). Younger-aged children had higher peak IOP (r = -0.244, P = 0.048), and attained the peak IOP earlier (r = 0.252, P = 0.041) in group A. There was no significant difference in ocular inflammatory response between the two groups.
Conclusion:
Ocular hypertensive effect to topical 0.1% dexamethasone is dose and age dependent in children. Twice-daily 0.1% topical dexamethasone eye drops control inflammation after strabismus surgery as effectively as four-times-daily dosage, but induces less increase in IOP, and may be a better treatment schedule.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems